Primary Site >> Biliary tract Cancer
Gene >> MT1E
| 1. | |||||||||||
| Journal: | Invest New Drugs. 2013 Aug;31(4):943-8. | ||||||||||
| Title: | A phase I study of sorafenib, oxaliplatin and 2 days of high dose capecitabine in advanced pancreatic and biliary tract cancer: a Wisconsin oncology network study. | ||||||||||
| Author: | LoConte, Noelle K|Holen, Kyle D|Schelman, William R|Mulkerin, Daniel L|Deming, Dustin A|Hernan, Hilary R|Traynor, Anne M|Goggins, Timothy|Groteluschen, David|Oettel, Kurt|Robinson, Emily|Lubner, Sam J | ||||||||||
| PMID: | 23263993 | ||||||||||
| 2. | |||||||||||
| Journal: | Invest New Drugs. 2017 Feb;35(1):95-104. | ||||||||||
| Title: | A phase I trial investigating pulsatile erlotinib in combination with gemcitabine and oxaliplatin in advanced biliary tract cancers. | ||||||||||
| Author: | Goff, Laura W|Cardin, Dana B|Whisenant, Jennifer G|Du, Liping|Koyama, Tatsuki|Dahlman, Kimberly B|Salaria, Safia N|Young, Ruth T|Ciombor, Kristen K|Gilbert, Jill|Smith, Stephen James|Chan, Emily|Berlin, Jordan | ||||||||||
| PMID: | 27853997 | ||||||||||